Medtronic, Abbott strike diabetes devices deal, giving patients more options Analysts see the partnership as positive for Medtronic, which has had some stumbles in its diabetes division.

Abbott has launched the FreeStyle Libre 2 Plus in India, a state-of-the-art continuous glucose monitoring system providing ...

FreeStyle Libre is a product that the healthcare company Abbott makes. The company’s headquarters are in Illinois, making various medical devices and health-related products.

Experts weigh the relative pros and cons of the new Freestyle Libre "Flash" Glucose Monitoring System, which seems to be gaining in popularity among diabetes patients in Europe.

Within medical devices, diabetes sales were up 15.8% led by FreeStyle Libre. Abbott expects its total 2024 revenue to rise 9.5% to 10% on an organic basis.

Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to kickstart the year.

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.

As diabetes device makers race to build completely hands-off artificial pancreas systems, Abbott’s CGMs are getting a significant upgrade.

The funds will support a regulatory filing with the FDA for ViCentra’s Kaleido pump and help upscale its manufacturing ...

Pharma giant Abbott said today it had received approval from the FDA for its next-generation glucose monitoring system for ages four and older with diabetes. The FreeStyle Libre 2 iCGM has a 14 ...